Temple Therapeutics is an innovative therapeutics and early diagnostics company that focuses on applying scientific innovations to the development of treatments and early detection diagnostics for tissue fibrosis, endometriosis, and ovarian cancer. They aim to make the temple of healing available to all, particularly women who suffer from untreated medical conditions, by providing access to effective and safe treatment options. Their mission is to serve the underserved and ensure medical progress is accessible to everyone.

They are dedicated to destigmatizing gynecological health, leading to less invasive treatments through early diagnostics, and promoting holistic healthcare that addresses physical, mental, and social well-being. Temple Therapeutics takes an inclusive approach to their research and development process. By gathering input from both patients and doctors, they identify areas where treatments are lacking and develop therapies, diagnostics, and devices to achieve bold outcomes.

Their commitment lies in bridging the gender and socioeconomic healthcare gap, improving long-term health and well-being outcomes, and empowering women to fully engage in their communities. Their holistic approach to diagnosis and treatment allows them to tackle interrelated diseases and conditions. Did you know that 70% of women with endometriosis suffer from adhesion? Temple Therapeutics has developed a groundbreaking drug, called surgi-ceutical, which is administered during surgery to minimize fibrotic tissue and encourage healthy tissue at the surgical site.

Additionally, women with endometriosis have a 50% greater risk of developing ovarian cancer. Temple Therapeutics is working on a blood biomarker test to catch ovarian tumors at less advanced stages. Temple Therapeutics is at the forefront of driving medical innovation and bringing hope to those in need of effective and accessible treatments